Iron for low iron anemia in young people with Crohn's disease
Studies iron supplements for anemia caused by low iron in young Crohn's patients.
Plain-language title generated from the registry record
Registry title: Iron Treatment for Iron Deficiency Anemia in Children and Young Adults With Crohn's Disease
Key facts
- Where
- New York, United StatesSee the site
- Phase
- Phase 4
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 3 and 21 years old?
Source: NCT07925450, who can take part
Where in United States
- Weill Cornell MedicineNew York, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Weill Medical College of Cornell University
- Trial code
- NCT07925450
- Record updated
- 9 November 2026
- Original description
Children and young adults with Crohn's disease may develop iron deficiency anemia, a condition in which low iron levels reduce the number of healthy red blood cells. This study aims to develop and test a model to help identify which iron treatment approached are most effective for these patients. Researchers will examine laboratory results, disease activity, treatment information, and information about bacteria in the digestive tract. Participants will be followed over time, and questionnaires will assess iron supplement use and related symptoms. The findings may help guide iron treatment for children and young adults with Crohn's disease.Read full original descriptionShow less
Developing and Validating a Predictive Model for the Management of Iron Deficiency Anemia in Pediatric Crohn's Disease Through Analysis of Microbiome and Patient Laboratory Data
Children and young adults with Crohn's disease may develop iron deficiency anemia, a condition in which low iron levels reduce the number of healthy red blood cells. This study aims to develop and test a model to help identify which iron treatment approached are most effective for these patients. Researchers will examine laboratory results, disease activity, treatment information, and information about bacteria in the digestive tract. Participants will be followed over time, and questionnaires will assess iron supplement use and related symptoms. The findings may help guide iron treatment for children and young adults with Crohn's disease.
Inclusion: Male or female; 3 to 21 years of age; Biopsy confirmed Crohns disease involving gastric, duodenal, and/or jejunal mucosa; Quiescent Crohns disease, assessed by histopathology, CRP, ESR, and PCDAI scores; Iron deficiency anemia, defined as hemoglobin or transferrin saturation below age-defined norms and/or MCV <80.
Exclusion: antibiotic use with 6 weeks of endoscopic evaluation.